BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16219060)

  • 21. Trisodium citrate: an alternative to unfractionated heparin for hemodialysis catheter dwells.
    Pierce DA; Rocco MV
    Pharmacotherapy; 2010 Nov; 30(11):1150-8. PubMed ID: 20973688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic anticoagulation related to heparin locking of non-tunnelled venous dialysis catheters in intensive care patients.
    Bong YC; Walsham J
    Anaesth Intensive Care; 2016 Jul; 44(4):474-6. PubMed ID: 27456177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different effects of enoxaparin and unfractionated heparin on some thrombogenesis markers during hemodialysis: a cross-over study.
    Naumnik B; Pawlak K; Myśliwiec M
    Thromb Res; 2009 Feb; 123(4):631-6. PubMed ID: 18234290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dermatan sulfate: an alternative to unfractionated heparin for anticoagulation in hemodialysis patients.
    Vitale C; Berutti S; Bagnis C; Soragna G; Gabella P; Fruttero C; Marangella M
    J Nephrol; 2013; 26(1):158-63. PubMed ID: 22419236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C
    Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bleeding and thrombosis in high-risk renal transplantation candidates using heparin.
    Mathis AS; Davé N; Shah NK; Friedman GS
    Ann Pharmacother; 2004 Apr; 38(4):537-43. PubMed ID: 14766999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of central venous hemodialysis catheter-related infection by a semiquantitative culture method.
    Brodersen HP; Beckers B; Clauss M; vom Dahl J; Floege J; Janssen U
    J Nephrol; 2007; 20(4):462-7. PubMed ID: 17879213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients.
    Mureebe L; Coats RD; Silliman WR; Shuster TA; Nichols WK; Silver D
    Surgery; 2004 Oct; 136(4):848-53. PubMed ID: 15467671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodialysis catheters with citrate locking in critically ill patients with acute kidney injury treated with intermittent online hemofiltration or hemodialysis.
    Skofic N; Buturović-Ponikvar J; Kovac J; Premru V; Knap B; Marn Pernat A; Kersnic B; Gubensek J; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):327-33. PubMed ID: 19695069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mathematical analysis of urea rebound in long-term hemodialysis patients.
    Ookawara S; Suzuki M; Saitou M; Tabei K
    Ther Apher Dial; 2005 Apr; 9(2):167-72. PubMed ID: 15828930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daily hemofiltration with a simplified method of delivery.
    Zimmerman DL; Swedko PJ; Posen GA; Burns KD
    ASAIO J; 2003; 49(4):426-9. PubMed ID: 12918585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Monitoring hemodialysis dose with ionic dialisance in on-line hemodiafiltration].
    Maduell F; Puchades MJ; Navarro V; Torregrosa E; Rius A; Sánchez JJ
    Nefrologia; 2005; 25(5):521-6. PubMed ID: 16392302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodialysis without anticoagulants: efficiency and hemostatic aspects.
    Casati S; Moia M; Graziani G; Cantaluppi A; Citterio A; Mannucci PM; Ponticelli C
    Clin Nephrol; 1984 Feb; 21(2):102-5. PubMed ID: 6723110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemodialysis of uremic patients with a high risk of bleeding].
    Qu SL; Chen QG
    Zhonghua Yi Xue Za Zhi; 1989 Mar; 69(3):131-3, 10. PubMed ID: 2776054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained low-efficiency dialysis in the ICU: cost, anticoagulation, and solute removal.
    Berbece AN; Richardson RM
    Kidney Int; 2006 Sep; 70(5):963-8. PubMed ID: 16850023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical evaluation of hemofiltration without anticoagulation in critically ill patients at high risk of bleeding].
    Yang RL; Liu DW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):651-5. PubMed ID: 18051723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different effect of unfractionated heparin and enoxaparin on circulating proangiogenic factors during hemodialysis: A cross-over study.
    Naumnik B; Pawlak K; Myśliwiec M
    Cytokine; 2007 Nov; 40(2):98-104. PubMed ID: 17920287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of sampling methods for obtaining accurate coagulation values in hemodialysis patients with heparinized central venous catheters.
    McLaren G; Hanna C; Mills L; Bourdeau J; Cowin R
    Nephrol Nurs J; 2001 Dec; 28(6):632-6. PubMed ID: 12143472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis.
    Burmeister JE; Scapini A; da Rosa Miltersteiner D; da Costa MG; Campos BM
    Nephrol Dial Transplant; 2007 Apr; 22(4):1184-9. PubMed ID: 17272314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical application of 4% sodium citrate and heparin in the locking of central venous catheters (excluding dialysis catheters) in intensive care unit patients: A pragmatic randomized controlled trial.
    Deng Y; Xing J; Tan Z; Ai X; Li Y; Zhang L
    PLoS One; 2023; 18(7):e0288117. PubMed ID: 37399185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.